HUMA - Humacyte, Inc.
About Humacyte, Inc. (https://www.humacyte.com)
Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs). Its investigational HAVs are designed to be easily implanted into any patient without inducing a foreign body response or leading to immune rejection. The company is developing a portfolio of HAVs, which would target the vascular repair, reconstruction, and replacement market, including vascular trauma; arteriovenous access for hemodialysis; peripheral arterial disease; and coronary artery bypass grafting, as well as developing its HAVs for pediatric heart surgery and cellular therapy delivery, including pancreatic islet cell transplantation to treat Type 1 diabetes. The company was founded in 2004 and is headquartered in Durham, North Carolina.
Key Executives
| NAME | TITLE | DOB | SALARY |
|---|---|---|---|
| Laura E. Niklason | Founder, President, Chief Executive Officer & Director | 1963 | $902,183 USD |
| Dale A. Sander | Chief Financial Officer, Chief Corporate Development Officer & Treasurer | 1960 | $735,503 USD |
| Shamik J. Parikh | Chief Medical Officer | 1973 | $700,401 USD |
| Heather Connelly | Executive Vice President Regulatory Affairs & Quality | – | – |
| Jim Mercadante | Chief Commercial Officer | – | – |
| Lisa Molyneux | Executive Vice President of Enterprise Planning & Analysis | – | – |
| Rick McElheny | Senior Vice President of Business Development | – | – |
| Sabrina Osborne | Chief People Officer | – | – |
| Todd E. Rasmussen | Chief Surgical Officer | – | – |